Incidence of human papillomavirus–related cancers among males and females aged 15-34 years in the United States

Postmarket surveillance of the incidence of human papillomavirus (HPV)–related cancers is essential to monitor the effectiveness of HPV vaccines. We directly compared HPV-related cancer incidences during the pre- and postvaccine era to assess the effects of HPV vaccination among vaccine-eligible age...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Fangjian, Adekanmbi, Victor, Hsu, Christine D, Berenson, Abbey B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029840/
https://www.ncbi.nlm.nih.gov/pubmed/36821427
http://dx.doi.org/10.1093/jncics/pkad016
_version_ 1784910224286547968
author Guo, Fangjian
Adekanmbi, Victor
Hsu, Christine D
Berenson, Abbey B
author_facet Guo, Fangjian
Adekanmbi, Victor
Hsu, Christine D
Berenson, Abbey B
author_sort Guo, Fangjian
collection PubMed
description Postmarket surveillance of the incidence of human papillomavirus (HPV)–related cancers is essential to monitor the effectiveness of HPV vaccines. We directly compared HPV-related cancer incidences during the pre- and postvaccine era to assess the effects of HPV vaccination among vaccine-eligible age groups in the United States using data from the US Cancer Statistics database. The 5-year average annual incidence rates for HPV-related cancers decreased in 2015-2019 compared with 2002-2006 among females aged 15-24 years and 25-34 years. Overall, a decrease in young males was not observed, whereas males aged 25-34 years experienced a slight decline in oropharyngeal squamous cell carcinoma between 2005-2009 and 2015-2019. Incidence rates for HPV-related cancers statistically significantly decreased in the vaccine era compared with the prevaccine era among females aged 15-34 years, suggesting the potential early effects of the introduction of HPV vaccination in the United States.
format Online
Article
Text
id pubmed-10029840
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-100298402023-03-22 Incidence of human papillomavirus–related cancers among males and females aged 15-34 years in the United States Guo, Fangjian Adekanmbi, Victor Hsu, Christine D Berenson, Abbey B JNCI Cancer Spectr Brief Communications Postmarket surveillance of the incidence of human papillomavirus (HPV)–related cancers is essential to monitor the effectiveness of HPV vaccines. We directly compared HPV-related cancer incidences during the pre- and postvaccine era to assess the effects of HPV vaccination among vaccine-eligible age groups in the United States using data from the US Cancer Statistics database. The 5-year average annual incidence rates for HPV-related cancers decreased in 2015-2019 compared with 2002-2006 among females aged 15-24 years and 25-34 years. Overall, a decrease in young males was not observed, whereas males aged 25-34 years experienced a slight decline in oropharyngeal squamous cell carcinoma between 2005-2009 and 2015-2019. Incidence rates for HPV-related cancers statistically significantly decreased in the vaccine era compared with the prevaccine era among females aged 15-34 years, suggesting the potential early effects of the introduction of HPV vaccination in the United States. Oxford University Press 2023-02-23 /pmc/articles/PMC10029840/ /pubmed/36821427 http://dx.doi.org/10.1093/jncics/pkad016 Text en © The Author(s) 2023. Published by Oxford University Press. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Communications
Guo, Fangjian
Adekanmbi, Victor
Hsu, Christine D
Berenson, Abbey B
Incidence of human papillomavirus–related cancers among males and females aged 15-34 years in the United States
title Incidence of human papillomavirus–related cancers among males and females aged 15-34 years in the United States
title_full Incidence of human papillomavirus–related cancers among males and females aged 15-34 years in the United States
title_fullStr Incidence of human papillomavirus–related cancers among males and females aged 15-34 years in the United States
title_full_unstemmed Incidence of human papillomavirus–related cancers among males and females aged 15-34 years in the United States
title_short Incidence of human papillomavirus–related cancers among males and females aged 15-34 years in the United States
title_sort incidence of human papillomavirus–related cancers among males and females aged 15-34 years in the united states
topic Brief Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029840/
https://www.ncbi.nlm.nih.gov/pubmed/36821427
http://dx.doi.org/10.1093/jncics/pkad016
work_keys_str_mv AT guofangjian incidenceofhumanpapillomavirusrelatedcancersamongmalesandfemalesaged1534yearsintheunitedstates
AT adekanmbivictor incidenceofhumanpapillomavirusrelatedcancersamongmalesandfemalesaged1534yearsintheunitedstates
AT hsuchristined incidenceofhumanpapillomavirusrelatedcancersamongmalesandfemalesaged1534yearsintheunitedstates
AT berensonabbeyb incidenceofhumanpapillomavirusrelatedcancersamongmalesandfemalesaged1534yearsintheunitedstates

Ejemplares similares